Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 3
1983 2
1985 1
1986 3
1987 3
1988 1
1989 3
1990 5
1991 5
1992 1
1993 4
1994 1
1995 2
1996 1
1997 2
1998 4
1999 4
2000 1
2001 9
2002 5
2003 9
2004 17
2005 11
2006 17
2007 7
2008 14
2009 16
2010 15
2011 27
2012 21
2013 21
2014 30
2015 25
2016 15
2017 13
2018 13
2019 21
2020 25
2021 32
2022 33
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Brand new norms for a good old test: Northern Italy normative study of MiniMental State Examination.
Foderaro G, Isella V, Mazzone A, Biglia E, Di Gangi M, Pasotti F, Sansotera F, Grobberio M, Raimondi V, Mapelli C, Ferri F, Impagnatiello V, Ferrarese C, Appollonio IM. Foderaro G, et al. Among authors: ferrarese c. Neurol Sci. 2024 May 17. doi: 10.1007/s10072-024-07585-7. Online ahead of print. Neurol Sci. 2024. PMID: 38755486 No abstract available.
The Clinical Spectrum of ANO3-Report of a New Family and Literature Review.
Percetti M, Zini M, Soliveri P, Cogiamanian F, Ferrara M, Orunesu E, Ranghetti A, Ferrarese C, Pezzoli G, Garavaglia B, Isaias IU, Sacilotto G. Percetti M, et al. Among authors: ferrarese c. Mov Disord Clin Pract. 2024 Mar;11(3):289-297. doi: 10.1002/mdc3.13979. Epub 2024 Jan 29. Mov Disord Clin Pract. 2024. PMID: 38284143 Review.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
419 results